5244

Syncom Formulations (India) Limited Stock Price

BSE:524470 Community·₹16.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 5 Fair Values set on narratives written by author

524470 Share Price Performance

₹16.98
-4.26 (-20.06%)
₹16.98
-4.26 (-20.06%)
Price ₹16.98

524470 Community Narratives

There are no narratives available yet.

Recent 524470 News & Updates

Syncom Formulations (India) Limited Key Details

₹4.9b

Revenue

₹3.2b

Cost of Revenue

₹1.7b

Gross Profit

₹1.2b

Other Expenses

₹575.6m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 14, 2025
Earnings per share (EPS)
0.61
Gross Margin
34.91%
Net Profit Margin
11.64%
Debt/Equity Ratio
1.3%

Syncom Formulations (India) Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet with solid track record.

0 Risks
2 Rewards

About 524470

Founded
1988
Employees
744
CEO
Vijay Bankda
WebsiteView website
www.syncomformulations.com

Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India and internationally. It operates through Manufacturing and Dealing in Pharmaceutical Drug and Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, dry syrups and suspensions, creams, gel, ORS, jelly, gynae, inhalers, opthal, ortho, and pediatrics formulations in dosage forms. It also provides life care, evolve, and the right nutrition products under the Cratus brand. In addition, the company offers its pharmaceutical formulation products in various dosage forms, such as tablets, capsules, ointments, injections, liquids orals, and effervescent. Syncom Formulations (India) Limited was incorporated in 1988 and is based in Indore, India.

Market Insight

Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading

Indian Market Performance

  • 7 Days: 0.9%
  • 3 Months: 0.2%
  • 1 Year: -4.1%
  • Year to Date: 1.6%
In the last week, the market has stayed flat, however the Information Technology sector stood out, gaining 3.8%. Unfortunately though, the market is down 4.1% over the past year. Looking forward, earnings are forecast to grow by 16% annually. Market details ›